Effect of Increased Muscular Work During Different Weaning Strategies in Critically Ill Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00538746|
Recruitment Status : Unknown
Verified October 2007 by Università degli Studi dell'Insubria.
Recruitment status was: Recruiting
First Posted : October 3, 2007
Last Update Posted : October 3, 2007
Most patients admitted to intensive care units require mechanical ventilation. Weaning from assisted/controlled ventilation begins when we recognize that the patient has recovered adeguately from acute respiratory failure.
If weaning is delayed, costs are increased, as are the risks of nosocomial pneumonia, cardiac-associated morbility, and death. On the other hand, weaning too soon often results in reintubation, which is associated with complications similar to those of prolonged ventilation.
The aim of this trial is to establish an evidence-based approach to weaning and to determine when a patient is ready to be weaned from mechanical ventilation, and what is the best weaning technique.
|Condition or disease||Intervention/treatment||Phase|
|Acute Respiratory Failure||Device: BIPAP Device: PSV Device: PSV + CPAP||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||February 2005|
BIPAP (Bilevel Positive Airway Pressure) targeted on: TV 6-8 ml/kg, total RR 10-30/min, PEEP and FiO2 regulated on Sat greater than 92% (with spontaneous RR between 20-40%)
PSV (pressure support ventilation) targeted on: TV 6-8 ml/kg,total RR 10-30/min, PEEP and FiO2 regulated on Sat greater than 92, a minimum of 7 cmH2O of PS is tolerated.
PSV+CPAP (continuous positive airway pressure) targeted on: PSV: TV 6-8 ml/kg,total RR 10-30/min, PEEP and FiO2 regulated on Sat greater than 92, a minimum of 7 cmH2O of PS is tolerated, CPAP (5-10 cmH2O) at least 2 hours a day. If during the CPAP periods at least 1 of the criteria T tube test failure occurs, the patients will come back immediately to PSV.
Device: PSV + CPAP
- 1. Days of intubation 2. Days of mechanical ventilation [ Time Frame: 28 days ]
- 1. The day of eventual tracheostomy 2. Organ Failure 3. The mortality at 28° day 4. Outcome at 6 months [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00538746
|Contact: Paolo Pelosi, Professoremail@example.com|
|Ospedale di Circolo e Fondazione Macchi||Recruiting|
|Varese, Italy, 21100|
|Contact: Paolo Pelosi, Professor 0039-0332-278801 firstname.lastname@example.org|
|Principal Investigator: Paolo Pelosi, Professor|
|Principal Investigator:||Paolo Pelosi, Professor||Universita' degli Studi dell'Insubria|